Current filters:  
Europe
Healthcare
Life Sciences, Biotechnology & Nanotechnology
Denmark
Plesner
From 1 April 2024, pharmaceutical companies must agree on an application date with the Danish Medicines Council's secretariat when they want an assessment of a new medicinal product.
Ireland
Marks & Clerk
With the Cheltenham Festival grabbing the majority of the sporting headlines this week, it's great to also see TrojanTrack making the final of the One-Zero start-up competition...
Switzerland
Kellerhals Carrard
What are important changes in regulation and what is to be expected from the markets in 2024? The co-heads of Kellerhals Carrard's Life Sciences Practice Group share their perspective on key developments.
Turkey
Gun + Partners
1262 sayılı İspençiyari ve Tıbbi Müstahzarlar Kanunu ("1262 sayılı Kanun") ile 3359 sayılı Sağlık Hizmetleri Temel Kanunu'nundaki ("3359 sayılı Kanun") klinik araştırma hükümlerinde değişiklik...
Gun + Partners
Named Patient Program ("NPP") is one of the exceptional pharmaceutical importation regimes for products that are not authorized or authorized...
Gun + Partners
On 1 March 2024, the Omnibus Law Amending Certain Laws and Decree Law No. 663 (the "Omnibus Law"), which amends certain provisions of the Law No. 1262 on Pharmaceuticals...
Esin Attorney Partnership
The Turkish Pharmaceuticals and Medical Devices Authority ("TİTCK") recently amended: i) the Decree on the Pricing of Pharmaceuticals, ii) the Guideline on the Classification...
Esin Attorney Partnership
Türkiye İlaç ve Tıbbi Cihaz Kurumu ("Kurum") geçtiğimiz haftalarda i) Beşeri Tıbbi Ürünlerin Fiyatlandırılmasına Dair Karar, ii)...
Gun + Partners
Yabancı ilaç markaları kural olarak o şirketlerin kurulduğu ülkelerdeki firmalar adına kayıtlıdır ve marka koruma işlemleri o firmalar tarafından yönetilir.
UK
Withers LLP
The products and innovations of life sciences businesses make an essential contribution to the health and quality of life of us all.
Gunnercooke
Between 2012 and 2015 the firm acted for a pharmacist client which wished to object to the intended relocation of a new competitor pharmacy within a short distance from its own retail pharmacy.
Marks & Clerk
It's been a massive month for the Liverpool City Region!...
Goodwin Procter LLP
Goodwin Partner Raymond Fang talks with TusPark's head of UK innovation and real estate, Wei Meng, about building life sciences ecosystems and the operational nature of real estate in the sector.
Venner Shipley
Gene therapy is considered to be one of the most exciting and promising forms of medical treatments available today...
Venner Shipley
Artificial Intelligence (AI) is a rapidly growing field that has been making significant contributions to various industries, including the pharmaceutical industry.
Arnold & Porter
Publication of a Roadmap for the Future Regulation of Medical Devices in the UK. On January 9, the Medicines and Healthcare products Regulatory Agency...
European Union
Gunnercooke
The case concerned a claim against our client for alleged infringement of the claimant's international registered trademark for a pharmaceutical preparation.
Mayer Brown
The EU Data Act came into force on January 11, 2024.
Osborne Clarke
On 26 January 2024, the European Commission published a report, "Update on competition enforcement in the Pharmaceutical Sector (2018-2022)".
Novagraaf Group
Chaque année, il est mis en lumière une question liée à la facilitation de la contrefaçon ou du piratage. Cette année, le point particulier était celui des risques potentiels pour...
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Mondaq Social Media